Panel Says to Keep Saccharin an ‘Anticipated’ Carcinogen

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 6 No 12
Volume 6
Issue 12

RESEARCH TRIANGLE PARK, North Carolina-Saccharin just missed winning a reprieve. By a 4-to-3 vote, an advisory panel recommended that the federal government continue to list the artificial sweetener as “reasonably anticipated to be a human carcinogen.”

RESEARCH TRIANGLE PARK, North Carolina—Saccharin just missed winning a reprieve. By a 4-to-3 vote, an advisory panel recommended that the federal government continue to list the artificial sweetener as “reasonably anticipated to be a human carcinogen.”

The board of scientific counselors of the National Toxicology Program also recommended that the 9th edition of the federal “Report on Carcinogens” list ultraviolet light as a known human carcinogen, whether the source is sunlight or a tanning bed or booth.

Working under new rules that permit the listing of chemical mixtures as well as single chemicals, the board further urged that smokeless tobacco and inhaled tobacco smoke be added to the list of “known” human carcinogens. Certain chemicals present in tobacco and tobacco smoke already carry the “known” designation. The advisory group, however, sought to emphasize that tobacco products as a whole, whether smoked, chewed, or snorted, can cause cancer in humans.

Although the board recommended listing of the antiestrogen tamoxifen (Nolvadex) as a known human carcinogen, it also strongly emphasized that the drug’s benefits in preventing breast cancer recurrence greatly outweigh its risks.

In its saccharin decision, the board rejected the advice of the scientific review committees of the National Institute of Environmental Health Sciences and the Interagency Committee Working Group for the Report on Carcinogens. Saccharin was labeled an “anticipated” carcinogen in 1981 on the basis of animals studies, including a 1977 Canadian rat study.

Among the other recommendations:

  • Add to the list of known human carcinogens benzidine dyes, used in textiles, paper, and leather, and strong inorganic acid mists containing sulfuric acid, used in making fertilizers, explosives, and plastics, and in petroleum refining.
  • Raise from “anticipated” to “known” carcinogen, cadmium, used in batteries; 1,3-butadiene, used in making synthetic rubber; and dioxin, an impurity formed in herbicide manufacture, incineration, and several industrial processes.
  • Add as “anticipated” carcinogens trichloroethylene, an industrial solvent once used to decaffeinate coffee; chloroprene, used in industrial rubber products and in adhesives in food packaging; and phenolphthalein, an ingredient once used in nonprescription laxatives.
Recent Videos
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
Related Content